Exploratory Study Assessing Synchronisation of Egg Sacs With Degarelix

NCT00434122 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Infertility, Female

Interventions

DRUG: Degarelix mid-luteal, 2.5 mg
DRUG: Placebo

Sponsor

Ferring Pharmaceuticals